Development of a New Approach for the Therapy of Prostate Cancer with SPOP Mutations

作者
David M. Lu,Jason J. Lee,Allen J. Lee,Ray M. Lee
出处
期刊:Journal of Cancer Therapy [Scientific Research Publishing]
卷期号:06 (10): 841-848 被引量:3
标识
DOI:10.4236/jct.2015.610092
摘要

Advanced prostate cancer is treated with androgen deprivation, but most patients eventually progress and need new therapy. Recent genomic/exomic sequencing identified SPOP as the most frequently mutated gene in 6% - 15% of prostate cancer. Based on the function of SPOP as a ubiquitin ligase in protein degradation, it was hypothesized that loss-of-function mutations of SPOP led to accumulation of SPOP substrates that enhance androgen receptor activity and facilitate prostate cancer formation. SPOP substrates could thus be potential targets for treatment of androgen-sensitive prostate cancer. PubMed and BLAST search identified that Gli, SRC-3, and AWP1 are SPOP substrates, and that inhibition of PRK-1, a binding partner of AWP1, by lestaurtinib suppressed androgen receptor activity. LNCaP, PC3, DU145 and 22RV1 prostate cancer cells were used to evaluate the effect of lestaurtinib. LNCaP cells, an androgen-sensitive prostate cancer cell line, were the most sensitive. SRC-3 protein decreased when LNCaP cells were treated with lestaurtinib; whereas PRK-1 increased in nucleus after lestaurtinib treatment. These data suggest that lestaurtinib modulates SRC-3 and PRK-1 to induced cell death in androgen-sensitive prostate cancer, and could be a useful agent for future development for prostate cancer with SPOP mutations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
2秒前
2秒前
2秒前
大模型的应助被文静的飞柏采纳,获得10
2秒前
3秒前
3秒前
3秒前
4秒前
隐形曼青的应助被科研通管家采纳,获得10
4秒前
369ninja发布了新的文献求助10
4秒前
NexusExplorer的应助被科研通管家采纳,获得10
4秒前
852的应助被科研通管家采纳,获得10
4秒前
Jasper的应助被科研通管家采纳,获得10
4秒前
4秒前
醋溜滑板完成签到,获得积分10
4秒前
Ava的应助被科研通管家采纳,获得10
4秒前
充电宝的应助被科研通管家采纳,获得30
5秒前
5秒前
田様的应助被科研通管家采纳,获得10
5秒前
ay的应助被XIN采纳,获得10
5秒前
CipherSage的应助被科研通管家采纳,获得10
5秒前
华仔的应助被科研通管家采纳,获得30
5秒前
星辰大海的应助被科研通管家采纳,获得10
5秒前
秋风的应助被科研通管家采纳,获得20
5秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
情怀的应助被科研通管家采纳,获得10
6秒前
完美世界的应助被科研通管家采纳,获得10
6秒前
shangguang的应助被科研通管家采纳,获得50
6秒前
6秒前
JamesPei的应助被科研通管家采纳,获得10
6秒前
勤恳兔子的应助被科研通管家采纳,获得10
6秒前
所所的应助被科研通管家采纳,获得10
6秒前
Akim的应助被科研通管家采纳,获得10
6秒前
Ava的应助被bow采纳,获得10
6秒前
7秒前
7秒前
placebo发布了新的文献求助10
7秒前
一叶扁舟发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181279
求助须知:如何正确求助?哪些是违规求助? 9571198
关于积分的说明 21817073
捐赠科研通 7777612
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479519